SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Samsung Bioepis Seeks U.S. Approval for Keytruda Biosimilar

Samsung Bioepis has applied for U.S. approval of a Keytruda biosimilar.

Related stories